Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Stock Price, Quote & AI Analysis

Live RXRX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Recursion Pharmaceuticals, Inc. Class A Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
3.440000
High
4.040000
Low
3.440000
Volume
38,832,211
VWAP
-
Market Cap
$2,326,443,706.35
52W Range
$2.77 - $7.18
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 3, 2026 Q2
Market
EPS Estimate: $-0.2681
Revenue Estimate: $17,806,282.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Recursion Pharmaceuticals, Inc. Class A Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Recursion Pharmaceuticals, Inc. Class A Common Stock Overview

Company information

Company Overview

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.

Company Details
Market Cap
$2.01B
Shares Outstanding
530,762,333
Weighted Shares Outstanding
520,457,205
CEO
Najat Khan
Address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Employees
800
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Recursion Pharmaceuticals, Inc. Class A Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...